Scientific context. Not medical advice.
VESTRIKSCIENCE. STRUCTURE. TRACEABILITY.
Search
Menu

Research catalogue

TIRZEPATIDE – auto-injector pen

Dual-receptor peptide agonist

  • Glucose metabolism research
  • Body-weight regulation research
  • Metabolic research

Substance research context; not a claim of efficacy or approval for this product.

Scientific profile and evidence limitations

€110,00

Scientific context. Not medical advice.

Availability
Out of stock

Quantity discount is inactive. The regular variant price is shown; no discount is applied in cart or checkout.

Cart

Purchasing and payment are unavailable. Catalogue products are out of stock.

Planned offers · inactive

€100 qualifying merchandise value → 1 BAC Water gift. Product, inventory and gift terms require approval.

€250 qualifying merchandise value → free shipping in approved zones only. Rates and zones require approval.

Progress is not calculated: these offers do not apply in cart or checkout. No gifts are added.

Laboratory accessories

Full cart page

Product overview

TIRZEPATIDE catalogue record. Form: auto-injector pen. Declared catalogue quantities: 20mg, 30mg, 40mg, 50mg, 60mg.

Product information

The quantity describes the catalogue variant, not a dosing or administration recommendation.

Documentation and artwork

Owner-authorized generic catalogue artwork is not a photograph of a specific batch and does not establish purity, testing or certification. No verified batch-linked COA is provided. Storage and handling information awaits actual supplier documentation; no unverified temperature or expiry is stated.

This is an informational catalogue entry. Orders are not accepted. No instructions for human or veterinary use are provided.

Research context

Dual-receptor peptide agonist

  • Glucose metabolism research
  • Body-weight regulation research
  • Metabolic research

Substance research context; not a claim of efficacy or approval for this product.

Dual incretin-receptor signalling is supported for the studied molecule. It is not proof of identity or activity of supplier material. GIP and GLP-1 agonism does not establish that any material bearing the name matches the clinical preparation.

Study types in selected sources: In vitro · Animal / preclinical · Phase I · Phase III

Preclinical findings are not clinical efficacy evidence. Human findings concern the studied preparation, not this supplier product.

Scientific profile and evidence limitations

Product specifications

CAS
Unknown
Formula
Unknown
Molecular weight
Unknown
Purity result
No verified purity result is available.
Storage
Storage information is not yet available.

Documents and batches

Batch documentation is not yet available.

View laboratory records

Compound information

TIRZEPATIDE – auto-injector pen

Educational substance profile

Research and references

Scientific references are not yet available.

Educational substance profile

Shipping & support

Contact support for delivery information.

Support & shipping

Other approved catalogue options

VESTRIK

Welcome to VESTRIK

This website provides a product catalogue and scientific and educational information. Before continuing, read the terms and select all four acknowledgements.

This acknowledgement is not a purchase contract and does not override product restrictions or legal requirements.

Read the terms in this window

Updated 2026-10-12. Orders and payments are currently unavailable. All catalogue products are out of stock. These purchase terms apply only to lawfully offered products when sales are enabled; this text does not activate sales.

Seller and contact

UAB Aromagama, company code 305243105, VAT LT100012643616. Registered office and returns address: Mokolų g. 5, LT-68172 Marijampolė, Lithuania. Email: uab.aroma.gama@gmail.com. Phone: +37068935779.

Ordering and contract formation

Once sales are enabled, the buyer selects an available product and variant, reviews quantity, contact details, delivery, total cost and payment method, reads these terms and accepts them before payment. An order is the buyer’s offer to purchase; the contract is formed when the seller confirms acceptance by email. An automatic acknowledgement or B2B enquiry alone is not acceptance. The confirmation provides the contract terms in a format that can be saved. This sales process is currently inactive.

Prices and payment

Catalogue prices are in euros (EUR). Approved retail prices include VAT; the final total and delivery charge must be disclosed before an obligation to pay is assumed. VESTRIK currently accepts no payments: no purchasing payment methods are active. MakeCommerce is the intended processor, but the VESTRIK integration has not been activated. Bank or card methods will be offered only following provider approval and activation of the particular methods. Naming a platform does not mean all its methods will be available.

Shipping

No orders are currently shipped. The EU warehouse is in Lithuania. Planned dispatch is within 1 business day; delivery to European countries typically takes 5–10 business days, without a guaranteed transit time. Dispatch and carrier delivery are separate stages. The current Shopify standard domestic rate is EUR 5.99; a remaining free-delivery setting from EUR 40 conflicts with the approved future policy. The technical international rate is EUR 17, but final destinations, carriers and charges are not approved. Sales will not be enabled with unreconciled delivery terms. The intended policy has no free delivery. Approved methods and exact charges will be published before sales begin and displayed before payment.

Consumer withdrawal and refunds

A consumer normally has 14 days after receiving goods to notify withdrawal from a distance contract, then 14 days to return them. Email the seller with the order number and a clear withdrawal statement; use the returns address above. The buyer bears direct withdrawal return shipping costs. Rights concerning defective goods are unaffected.

The amount paid and standard outbound delivery charge are refunded within 14 days of notice, using the original method unless otherwise agreed without a fee. The seller may withhold repayment until receiving the goods or evidence of dispatch. An extra charge for a more expensive chosen delivery method is not refunded.

Exceptions apply only where the actual goods meet statutory conditions—for example, unsealed goods unsuitable for return for health-protection or hygiene reasons. “Peptide”, “research” or “syringe” labels alone do not create an exception. Actual packaging and characteristics require assessment; there is no catalogue-wide returns exclusion. Mandatory remedies for defects remain.

Complaints

Contact the seller in writing or by email, stating the requested remedy and purchase details. A reasoned response is provided within 14 calendar days. Unresolved disputes may be referred to VVTAT or a court. Mandatory consumer rights are preserved.

Product-specific restrictions

The catalogue contains peptide and biochemical compounds in different presentations and insulin syringes; retatrutide and tirzepatide categories are not concealed. Sale eligibility, intended use and claims require individual approval. A listing, zero stock or an 18+ acknowledgement does not authorize sale. Scientific profiles are neither specific-batch analysis nor treatment advice. VESTRIK is not exclusively B2B or laboratory-only and currently enforces no such customer restriction. Sales of unapproved or restricted products are not enabled.

Open the terms page (new window)
Leave Website

A first-party cookie remembers the acknowledgement for 30 days. This is not verification of identity, age or professional qualifications. Cookie consent is managed separately; this action does not grant analytics or marketing consent.

Privacy